IHC - Pitutary Lesion Hormones (Prolactin, Growth Hormone, LH, FSH, ACTH,TSH)

The IHC – Pituitary Lesion Hormone Panel is an advanced immunohistochemistry (IHC) diagnostic test used to evaluate pituitary gland tumors and lesions by detecting hormone expression in tissue samples. This panel includes six essential pituitary hormones: Prolactin, Growth Hormone (GH), Luteinizing Hormone (LH), Follicle Stimulating Hormone (FSH), Adrenocorticotropic Hormone (ACTH), and Thyroid Stimulating Hormone (TSH).

The pituitary gland is known as the body’s “master gland” because it regulates many important hormonal functions. Abnormal growths or tumors in the pituitary gland may produce excess hormones or remain non-functioning. This test helps identify the specific hormone profile of the lesion, allowing accurate classification of pituitary adenomas and other pituitary neoplasms.

The panel plays a critical role in determining whether a pituitary tumor is hormone-secreting and helps guide treatment decisions such as surgery, medical therapy, or long-term monitoring.

Benefits of the Test

The Pituitary Lesion Hormone Panel offers several important clinical benefits:

• Detects hormone production in pituitary tumor tissue
• Identifies functional pituitary adenomas
• Helps classify pituitary tumor subtype accurately
• Distinguishes hormone-secreting from non-functioning lesions
• Supports treatment planning and prognosis assessment
• Improves overall diagnostic precision

This test is essential for comprehensive pituitary pathology evaluation.

Why Doctors Recommend This Test

Doctors recommend this panel when a pituitary lesion or tumor is identified on imaging or surgery.

It is commonly advised for:

• Suspected pituitary adenoma evaluation
• Functional hormone-producing pituitary tumors
• Pituitary tumor subtype classification
• Endocrine dysfunction caused by pituitary lesions
• Cases requiring detailed pathological confirmation

The results help endocrinologists, neurosurgeons, and oncologists choose the most effective treatment strategy.

Preparation Before Test

No special preparation is required from the patient. The test is performed on previously collected pituitary tissue biopsy or surgical specimens.

Normal Reporting Time

The typical turnaround time for the Pituitary Lesion Hormone Panel is 3 to 5 working days, depending on sample complexity and laboratory workflow.

Who Should Take This Test

This test is recommended for:

• Patients diagnosed with pituitary tumors
• Individuals with hormone-related pituitary disorders
• Patients with suspected pituitary adenoma
• Cases needing hormone subtype classification
• Patients undergoing pituitary surgery evaluation

The IHC Pituitary Lesion Hormone Panel is a vital diagnostic tool in endocrine pathology. It accurately identifies hormone-producing pituitary lesions, supports precise diagnosis, and helps doctors plan targeted treatment for improved patient outcomes.